Drug Name |
Oxytetracycline hydrochloride |
Drug ID |
BADD_D01651 |
Description |
A tetracycline analog isolated from the actinomycete streptomyces rimosus and used in a wide variety of clinical conditions. |
Indications and Usage |
Oxytetracycline is indicated for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae (respiratory infections), and Diplococcus pneumoniae. |
Marketing Status |
approved; investigational; vet_approved |
ATC Code |
D06AA03; J01AA06; S01AA04; G01AA07; A01AB25 |
DrugBank ID |
DB00595
|
KEGG ID |
D01596
|
MeSH ID |
D010118
|
PubChem ID |
54680782
|
TTD Drug ID |
D0J2NK
|
NDC Product Code |
24507-003; 71057-0100; 54509-0002; 51671-0003; 82403-002 |
UNII |
4U7K4N52ZM
|
Synonyms |
Oxytetracycline | Hydroxytetracycline | Geomycin | Oxyterracin | Oxyterracine | Oxytetracid | Oxytetracycline Calcium | Oxytetracycline Dihydrate | Oxytetracycline Hydrochloride | Oxytetracycline Monohydrochloride | Oxytetracycline Sulfate (2:1) | Oxytetracycline, (4a beta,5 beta,5a beta,12a beta)-Isomer | Oxytetracycline, (5 beta)-Isomer | Oxytetracycline, Anhydrous | Oxytetracycline Anhydrous | Oxytetracycline, Calcium (1:1) Salt | Oxytetracycline, Disodium Salt, Dihydrate | Oxytetracycline, Sodium Salt | Terramycin | Bisolvomycin |